Month: March 2025

Toll Brothers Announces New Sanderling Bay Community Now Open in Pawleys Island, South Carolina

Written by Customer Service on March 27, 2025. Posted in Public Companies.

PAWLEYS ISLAND, S.C., March 27, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of Sanderling Bay, an intimate community of luxury homes in Pawleys Island, South Carolina. Located just minutes from the beach, Sanderling Bay presents an extraordinary opportunity for residents to embrace a coastal lifestyle. The community is located at Petigru Drive and Martin Luther King Road in Pawleys Island and is now open for sale by appointment at an off-site Sales Center. Sanderling Bay is an intimate community of just 22 single-story homes offering the opportunity to create a dream escape in a quiet beach town. Residents can spend their days relaxing at Litchfield Beach, golfing at any of this area’s top clubs, or exploring the exciting shopping and dining...

AgriForce Growing Systems to Participate in Entrepreneurs’ Organization Event at Morgan Stanley’s New York City Offices

Written by Customer Service on March 27, 2025. Posted in Public Companies.

Vancouver, British Columbia and West Palm Beach, FL, March 27, 2025 (GLOBE NEWSWIRE) — Jolie Kahn, CEO of AgriFORCE Growing Systems, Ltd., a NASDAQ listed company (NASDAQ:AGRI), will be a panelist on “The Art of the Acquisition; Growing Your Company Using Mergers and Acquisitions”. The event will be hosted by Morgan Stanley at their offices in New York City on the evening of March 27th at 6pm EST. The event is being produced by the New York chapter of the Entrepreneurs’ Organization (EO), a global membership organization of over 20,000 members who are CEOs of companies with revenues in excess of $1 million. Currently over 100 CEOs are registered for the event. Ms. Kahn will be discussing AgriFORCE’s recent acquisitions of Bitcoin mining facilities and how the recent shift to operating in the Bitcoin mining...

Alterra IOS Acquires Two Industrial Outdoor Storage Sites In Southern New Jersey

Written by Customer Service on March 27, 2025. Posted in Mergers And Acquisitions.

Acquisitions grow Alterra’s New Jersey footprint to 15 properties, expanding the firm’s presence in the Garden StateSWEDESBORO, N.J., March 27, 2025 (GLOBE NEWSWIRE) — Alterra IOS, a prominent player in the industrial outdoor storage (IOS) sector that has acquired over 300 sites nationwide, today announced the acquisition of two IOS properties totaling seven usable acres in Southern New Jersey. The parcels include 223 Paulsboro Road in Swedesboro and 189 Dominic Lane in Paulsboro. “South Jersey’s strategic location offers a gateway to Philadelphia and other major cities along the I-95 corridor, making it an appealing market for IOS investment,” said Mark Gannon, Senior Vice President of Acquisitions at Alterra IOS. “These acquisitions offer national tenants an opportunity for East Coast expansion and provide access to the Mid-Atlantic’s...

TransPerfect Acquires German Media Localization Studio SPEEECH

Written by Customer Service on March 27, 2025. Posted in Mergers And Acquisitions.

MUNICH and NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) — TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced that it has acquired the Munich-based dubbing and localization company SPEEECH Audiolingual Labs. SPEEECH will become part of TransPerfect Media, TransPerfect’s media and entertainment division. Financial terms of the transaction were not disclosed. SPEEECH specializes in German and multilingual adaptions for the entertainment industry. The company’s studio facilities include six recording rooms and two mixing rooms, enhancing TransPerfect’s capabilities to provide locally nuanced services for films, series, online videos, games, commercials, and OTT content to clients in the region. “Joining TransPerfect opens up opportunities for us to expand our services globally,”...

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

Written by Customer Service on March 27, 2025. Posted in Earnings Releases And Operating Results.

— Company expands commercial product offering with FemBloc® permanent birth control (delivery system) approval in Europe and signed partnerships for distribution in Spain — ATLANTA, March 27, 2025 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, announces financial results for the year ended December 31, 2024 and provides a corporate update. Corporate Highlights from 4Q 2024 to dateAnnounced FemBloc® permanent birth control (delivery system) approval in Europe; FemBloc blended polymer component successfully completed an expedited G12 Special MDR Audit for Class III devices, and the Notified Body has recommended for CE mark approval...

SAIHEAT Announces Joining 1CP Program to Optimize Energy Costs for Bitcoin Mining

Written by Customer Service on March 27, 2025. Posted in Public Companies.

SINGAPORE, March 27, 2025 (GLOBE NEWSWIRE) — SAIHEAT Limited (f/k/a SAI.TECH Global Corporation) (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW), is pleased to announce its participation in the 1CP (AEP’s Critical Peak) program, a strategic initiative designed to reduce electricity costs for energy-intensive industries. This initiative aligns with SAIHEAT’s mission to enhance operational efficiency and sustainability in the digital asset sector. The 1CP program is modeled after The AEP Ohio Basic Transmission Cost Rider (BTCR) pilot program, approved by the Public Utilities Commission of Ohio (PUCO) as part of Electric Security Plan V (ESP V). This program enables select interval-metered customers to have their demand-based BTCR charges calculated based on their load during AEP’s critical peak (1CP) instead of their monthly...

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

Written by Customer Service on March 27, 2025. Posted in Public Companies.

Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the American Society for Gastrointestinal Endoscopy (ASGE) updated its guideline on the diagnosis and management of gastroesophageal reflux disease (GERD) to include Transoral Incisionless Fundoplication (TIF 2.0) and TIF 2.0 Consecutive Transoral Incisionless Fundoplication (cTIF)* procedures as evidence-based approaches to care. GERD occurs when stomach acid flows into the esophagus, causing irritation of the tissue lining. Uncomfortable symptoms can include heartburn, upper stomach or chest pain, trouble swallowing, and chronic cough. A common chronic condition,...

TEN Ltd. Reports Profits for the 12 Months and Fourth Quarter Ended December 31, 2024 and Announces Common Share Dividend

Written by Customer Service on March 27, 2025. Posted in Earnings Releases And Operating Results.

Dynamic 21 vessel expansion – 36% dwt growth – 82 vessel proforma fleet. Doubling minimum contracted revenues to $4.0 billion Adjusted EBITDA of $400 million and Net income of $176 million for 2024 Annual EPS of $5.03 and $0.42 for the 2024 fourth quarter Nine DP2 shuttle tankers on long-term employment to Brazil’s Transpetro with expected contracted revenues of $2.0 billion positioning TEN as one of the largest shuttle tankers owners in the world – Proforma Shuttle fleet of 16 vessels all on fixed employment Sale of 2009-built suezmax generates $30.0 million in free cash as part of ongoing fleet renewal Uninterrupted dividend payments since NYSE listing in 2002 Market fundamentals remain strong ATHENS, Greece, March 27, 2025 (GLOBE NEWSWIRE) — TEN, Ltd (TEN) (NYSE: TEN) (the “Company”) today reported results...

ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Written by Customer Service on March 27, 2025. Posted in Earnings Releases And Operating Results.

KEY HIGHLIGHTS:Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025.Regulatory path for VAR 200’s lead indication, focal segmental glomerulosclerosis (FSGS), expected to be shorter based on FDA’s alignment with data supporting proteinuria reduction as a clinical trial endpoint for approval of FSGS drugs (Parasol Initiative).Obesity proof-of-concept studies with Inflammasome ASC Inhibitor IC 100 in diet-induced obesity (DIO) mouse models are planned to begin H1-2025. Investigational New Drug Application (IND) for IC 100 is anticipated to be submitted H2-2025, followed by initiation of a Phase 1 clinical trial in healthy overweight subjects. Preclinical study funded by The Michael J. Fox Foundation (MJFF) to evaluate the potential...

Carlyle Secured Lending, Inc. Closes Merger with Carlyle Secured Lending III

Written by Customer Service on March 27, 2025. Posted in Mergers And Acquisitions.

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) — Carlyle Secured Lending, Inc. (“CGBD”) (NASDAQ: CGBD) announced today the closing of its previously announced merger with Carlyle Secured Lending III (“CSL III”) with CGBD as the surviving company. Based on March 25, 2025 financial data, the combined company has more than $2.8 billion of assets. In connection with the closing of the merger, CSL III shareholders received 18,935,108 shares of CGBD common stock for each common share of CSL III based on the final exchange ratio and payment of cash in lieu of fractional shares. Prior to the closing of the merger, Carlyle Investment Management L.L.C. (“CIM”), a wholly owned subsidiary of Carlyle, exchanged its shares of CGBD convertible preferred stock for CGBD common stock at current NAV, eliminating the risk of dilution from the potential...

Month: March 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals